Intended for healthcare professionals


Ranitidine: doctors should switch patients to alternative, says health department

BMJ 2019; 367 doi: (Published 17 October 2019) Cite this as: BMJ 2019;367:l6087
  1. Elisabeth Mahase
  1. The BMJ

Doctors must identify and review patients with prescriptions for ranitidine tablets for gastrointestinal conditions and switch them to an alternative drug if ongoing treatment is still needed, the Department of Health and Social Care for England has said.1

In an alert sent on 15 October the department warned that all oral formulations of ranitidine were “anticipated to be out of stock, with no date for resupply until further notice.”

This came after the US …

View Full Text

Log in

Log in through your institution


* For online subscription